Instil Bio, Inc. Construction Payable, Current
Instil Bio, Inc. (TIL) had Construction Payable, Current of $60.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Notes
us-gaap:ConstructionPayableCurrent · last filed 2023-11-13
- 2023-09-30: Construction Payable, Current $60.00K.
- 2023-06-30: Construction Payable, Current $4.82M.
- 2023-03-31: Construction Payable, Current $9.55M.
- 2022-12-31: Construction Payable, Current $12.36M.
| Period end | Construction Payable, Current |
|---|---|
| 2023-09-30 | $60.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $4.82M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $9.55M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $12.36M 10-Q · filed 2023-11-13 |
| 2022-09-30 | $14.34M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $15.48M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $13.19M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $12.09M 10-K · filed 2023-03-31 |
| 2021-09-30 | $11.18M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $4.75M 10-Q · filed 2021-08-12 |
| 2020-12-31 | $302.00K 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |